This article briefly summarizes the epidemiology of the health effects of fine particulate air pollution, provides an early, somewhat speculative, discussion of the contribution of epidemiology to evaluating biologic mechanisms, and evaluates who's at risk or is susceptible to adverse health effects. Based on preliminary epidemiologic evidence, it is speculated that a systemic response to fine particle-induced pulmonary inflammation, including cytokine release and altered cardiac autonomic function, may be part of the pathophysiologic mechanisms or pathways linking particulate pollution with cardiopulmonary disease. The elderly, infants, and persons with chronic cardiopulmonary disease, influenza, or asthma are most susceptible to mortality and serious morbidity effects from short-term acutely elevated exposures. Others are susceptible to less serious health effects such as transient increases in respiratory symptoms, decreased lung function, or other physiologic changes. Chronic exposure studies suggest relatively broad susceptibility to cumulative effects of long-term repeated exposure to fine particulate pollution, resulting in substantive estimates of population average loss of life expectancy in highly polluted environments. Additional knowledge is needed about the specific pollutants or mix of pollutants responsible for the adverse health effects and the biologic mechanisms involved. Key words: air pollution, cardiopulmonary disease, health effects, life expectancy, particulate pollution, review.
It has long been known, or at least suspected, that there are adverse health effects associated with ambient air pollution (1) . Extreme air pollution episodes in the 1930s-1950s were associated with dramatically elevated cardiopulmonary morbidity and mortality. Evidence of serious health effects provided by these episodes spurred a growing concern about air pollution and in the United States during the 1950s through early 1970s, there was a series of legislative efforts related to trying to control air pollution. Current air pollution legislation is based largely on the 1970 Clean Air Act and 1990 Amendments to this act (2) . The amended Clean Air Act mandated national ambient air quality standards for pollutants that are relatively common and widespread but may reasonably be anticipated to endanger public health. Six pollutants that met these basic criteria (criteria pollutants) were eventually selected, including particulate matter (PM), sulfur dioxide, nitrogen dioxide, carbon monoxide, ozone, and lead. Since 1970 there have been hundreds of published studies that have evaluated the health effects of these air pollutants. A 1996 review of the health effects of these criteria pollutants (along with two other common pollutants) was prepared by the Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society (ATS) (2) . There have also been numerous recent reviews that have focused on health effects of particulate air pollution (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . This article does not attempt to replicate the excellent ATS review of all the criteria pollutants or previous general reviews of particulate air pollution. The overall plan of this article is to focus on three basic topics. First, the epidemiology of the health effects of fine particulate air pollution PM2.5 (particles < 2.5 pm) will be briefly summarized, although recent, more comprehensive reviews are available. This summary relies heavily on updates of several previous reviews by Dockery and Pope (6, (8) (9) (10) (11) . Second, a somewhat speculative discussion of the early but clearly incomplete contribution of epidemiology to evaluating the biologic mechanisms is provided. This discussion of biologic mechanisms is updated from papers originally prepared for presentation at international symposia (10, 11) . Finally, an original discussion of who risks adverse health effects due to exposure to fine particulate air pollution is presented.
Characteristics of Fine Particles
Particulate air pollution refers to an airsuspended mixture of solid and liquid particles that vary in size, composition, and origin. The size distribution of total suspended particles (TSPs) in the atmosphere is trimodal and includes coarse particles, fine particles, and ultrafine particles. Coarse 47 0.4 'Based on updated summary estimates from previous reviews (6, 8, 10 (16) (17) (18) (19) (20) (21) and hospitalization or related health care end points ( Table 1) . Most of these studies have evaluated associations between respiratory hospital admissions and air pollution. Several studies have also analyzed emergency department visits for asthma, chronic obstructive pulmonary disease, and other respiratory ailments, and observed associations with partic- ulate air pollution. More recent studies have observed associations between particulate air pollution and hospitalizations for cardiovascular disease (73, 74, 87, (98) (99) (100) 
Effects of Chronic Exposure
The previously discussed acute exposure studies indicate that short-term exposures to elevated particulate air pollution are associated with short-term changes in cardiopulmonary health. These acute exposure studies provide little information about how much life is shortened, how pollution affects longer-term mortality rates, or pollution's potential role in the process of inducing chronic disease that may or may not be life threatening. Chronic exposure studies evaluate health end points across communities or neighborhoods with different levels of average pollution over longer time periods (usually 1 year or more). Chronic exposure studies attempt to evaluate the effects of low or moderate exposure that persists for long periods as well as the cumulative effects of repeated exposure to substantially elevated levels of pollution. A brief summary of the results of the chronic exposure studies is provided in Table 3 .
Mortality Rates
Several population-based, cross-sectional mortality studies have evaluated associations between annual mortality rates and particulate air pollution across U.S. metropolitan areas ( Table 3 ). The basic conclusions from these population-based cross-sectional studies were that mortality rates were associated with air pollution, and they were most strongly associated with fine or sulfate PM. Such associations are illustrated in Figure 1 Whereas the population-based cross-sectional studies from the United States dealt with total mortality, a study from the Czech Republic focused on infant mortality (154) .
Infant mortality, especially respiratory postneonatal infant mortality, was strongly associated with particulate air pollution. All of these population-based cross-sectional PM1o data. Furthermore, the cohort was relatively small and was predominantly from only three metropolitan areas, San Diego, Los Angeles, and San Francisco.
Comparisons of mortality risk ratios for air pollution from the Six-Cities, ACS, infant mortality, and AHSMOG studies are presented in Table 4 . The estimated overall excess risk from the infant mortality study is similar to those estimated for adults in the Harvard Six-Cities and ACS studies, even though the time frame of exposure for the infants was clearly far shorter than for the adults. This observation suggests that the relevant time frame of exposure is short (a few months vs years) and/or that infants are at greater risk for exposure to air pollution.
Disea Lung Function
There have also been several studies evaluating associations between chronic exposure and particulate air pollution and respiratory symptoms and disease or lung function ( Table 3 ). The effects of air pollution on respiratory disease or symptoms were often estimated while adjusting for individual differences in various other risk factors. Significant associations between particulate air pollution and various respiratory symptoms were often observed. Chronic cough, bronchitis, and chest illness (but not asthma) were associated with various measures of particulate air pollution. Studies that evaluated effects of air pollution on lung function adjusted for individual differences in age, race, sex, height, and weight, and controlled for smoking or restricted the analysis to never-smokers. These studies observed small associations between decreased lung function and particulate air pollution that were often statistically significant.
Stylizd Summary ofEffects
The overall epidemiologic evidence is enhanced if adverse effects of exposure are reproducibly observed by different investigators in different settings. That is, there should be consistency of effects across independent studies. The evidence is further strengthened by a coherence of effects observed across a cascade of related health outcomes. Figure 2 presents a stylized summary of effect estimates of exposure to particulate air pollution. The effect estimates are not precise because different studies used various measures of pollution, different models, and differently defined health end points. In addition, the recent rapid growth of the literature in this area makes effect estimates a moving target. As illustrated in Figure 2 , a remarkable cascade of cardiopulmonary health end points has been observed. These include death from cardiac and pulmonary disease, emergency room and physician office visits for asthma and other cardiorespiratory disorders, hospital admissions for cardiopulmonary disease, increased reported respiratory symptoms, and decreased measured lung function. The (181) . The expected increase in mortality risk can then be estimated and compared with the PM-related cardiovascular mortality risk directly estimated from the PM mortality epidemiology studies. For example, the estimated decline in 24-hr SDNN associated with 100 pg/m3 PM1o was approximately 18 ms (SE = 4.9). Using the coefficients reported in these two studies (181, 187) , the estimated mortality risk ratio of an 18-ms decline in 24-hr SDNN can be calculated as 1.23 (e[l8*(lnl.62)/4.2]). This risk ratio seems somewhat plausible. It is larger than risk ratios for total or cardiovascular disease mortality that are generally estimated from daily timeseries studies but smaller than risk ratios estimated from the prospective cohort mortality studies oflong-term chronic exposure.
Two additional studies have also recently evaluated associations between particulate air pollution and HRV. One of these studies explored daily changes in HRV associated with daily changes in fine particulate air pollution with a panel of elderly subjects living in metropolitan Baltimore (180) . Daily ECG monitoring was conducted with resting, supine, 6-min R-R interval data collected each day. The second study involved subjects 53-87 years of age living in Boston, Massachusetts (182) . Weekly ECG monitoring was conducted using ambulatory (Holter) monitors continuously for 25 min, including 5 min of rest, 5 min of standing, 5 min of outdoor exercise, 5 min of recovery, and 20 cycles of slow breathing. Although the pollution levels were relatively low during the study periods in both of these studies, lower HRV was associated with elevated concentrations of fine particulate pollution, and the association was stronger for subjects with pre-existing cardiovascular conditions.
In the three currently available studies of particulate air pollution and HRV (180) (181) (182) , a negative association with particulate exposure and overall HRV was observed. The results, however, are not entirely consistent, especially with measures of the short-term (or high-frequency) components of HRV. To what degree these inconsistencies across studies can be explained by differences in ECG monitoring time frames, make-up of subjects, differences in pollution levels, or other differences needs to be explored.
A study of rabbits found that alveolar macrophage phagocytosis of small carbon particles < 10 pm in aerodynamic diameter resulted in the release of cytokines that led to stimulation of the bone marrow to release young polymorphonuclear leukocytes (PMNs). The authors postulated that these PMNs caused the health effects noted in epidemiologic studies (188) . A follow-up study was conducted of an air pollution episode due to fires in Southeast Asia in 1997 (183) . Blood samples from 30 healthy male military personnel were collected during and after the episode. The pollution episode was associated with significant increases in total white blood cell counts, band cells expressed as a percentage of PMNs, platelets, lymphocytes, and eosinophils. The authors suggest that these results imply a systemic response to PM-related pulmonary inflammation. A recent controlled human study of exposure to diesel exhaust also observed a well-defined and marked systemic and pulmonary inflammatory response in healthy human volunteers (184) .
The physiologic relevance of no PMrelated hypoxemia but PM-related changes in blood plasma viscosity, HR, HRV, and pulmonary inflammation is not well understood. Over a lifetime, the chronic exposure has the potential to eventually effect all. Although the exposures and effects for active cigarette smoking are much larger, cigarette smoking has been associated with a spectrum of cardiopulmonary diseases similar to those associated with fine PM. Interestingly, a decrease in HR and an increase in HRV have also been observed following smoking cessation (195) . Clearly, the answer to the question of who is susceptible is not simple but is dependent on the health effects being evaluated and the level and length ofexposure.
At Risk fiom Short-Term, Acute Exposure A summary of who may be susceptible to various adverse health effects from PM exposure and overall health relevance is presented in Table 6 . With respect to acutely elevated exposures, reflected by day-to-day changes in PM, those susceptible to dying are the elderly, the very young, and persons with chronic cardiopulmonary disease, influenza, or asthma. During the London episode of 1952, for example, approximately 80-90% of the excess deaths were in adults with respiratory and/or cardiovascular disease that was generally chronic in nature. There was also an approximate doubling of deaths in children less than 1 year of age (20) . As summarized in Table 2 , more recent daily time-series studies also observe that most of the excess mortality from PM exposure is from respiratory and cardiovascular disease deaths.
How much life shortening is due to acutely elevated levels of PM and how much of the mortality is due to short-term mortality displacement (harvesting) remains uncertain. If the increased mortality is only in the most frail persons with little remaining life expectancy, then death may be advanced by only a few days or weeks. However, recent research using data from Philadelphia, Pennsylvania observed that the increase in mortality was inconsistent with only shortterm mortality displacement and suggests that mortality for many may be substantially advanced (196) . These results also suggest that those who are susceptible to increased risk of mortality from acutely elevated PM may include more than just the most old and frail who are already very near death.
On any given day, the number dying due to PM exposure is extremely small. Based on the 1996 average death rate for the United States (8.8/1000/year) and the summary estimates presented in Table 2 , a 50-,ug/m3 increase in PM2.5 would result in an average of only 1.7 deaths per day per one million people (compared to an expected rate of approximately 24/day). This minimal excess deaths per day reflects the fact that the increased risk of mortality due to acutely elevated PM exposure is small, and on any given day there may only be a very small fraction of the population at serious risk of dying due to this acute exposure.
As summarized in Table 6 , the number of those susceptible to being hospitalized because of acute PM exposure is probably also quite limited and similar to the number of those at risk of dying. However, the number of those susceptible to less serious health effects such as increased respiratory symptoms, decreased lung function, or other physiologic changes may be quite broad. For most people, these effects are likely small, transient, and maybe even unnoticed. For a few, the decline in lung function may be clinically relevant (125) , or the effects may be result in short-term absence from work (131, 132) or school (141) .
At Risk from Long-Term Chronic posure Long-term, repeated PM exposure has been associated with increased population-based mortality rates (155) (156) (157) (158) (159) (160) as well as increased risk of mortality in broad-based cohorts or samples of adults (162, 163) and children (164) (Table 4) . Chronic exposure studies of PM suggest rather broad susceptibility to cumulative effects of long-term repeated exposure. There is no evidence that increased mortality risk is unique to any well-defined susceptible subgroup. All who are chronically exposed may ultimately be affected. However, because the relative risk is small, the longterm cumulative effects are most likely to be observed in older age groups with relatively higher baseline risks of mortality.
To illustrate the potential cumulative mortality effects of PM, survival curves and life expectancies have been estimated under six different scenarios illustrated in Figure 3 . The first curve is a baseline survival curve based on projected U.S. life tables prepared by the Office of the Chief Actuary in the Social Security Administration and obtained from the Berkeley Mortality Database (197) . Although a survival curve for never-smokers and for persons not exposed to urban air pollution was not directly calculated, this projected baseline curve is used to represent a reasonable baseline estimate for the total U.S. population. The life expectancy ofthis baseline curve is equal to 76.4 years.
The second, third, and fourth survival curves are calculated from the baseline curve assuming an additional relative risk of mortality from PM exposure equal to 1.25. This is approximately the relative risk estimated in both the Harvard Six-Cities study (162) and the postneonatal infant mortality study (164) for the relevant range of PM air pollution that exists in U.S. urban areas ( Table 4 ). The only difference between the second, third, and fourth curves is the age at which people begin to be susceptible to the effects of pollution. Curves two, three, and four assume that susceptibility begins at age 45 years, age 1 year, and at birth, respectively. As can be seen in Figure 3 , these three survival curves appear to be nearly identical. The close concurrence between these three curves is because the baseline mortality risk for infants, children, and young adults is so low compared to the baseline mortality risks for older adults. The estimated life expectancy for curves two, three, and four equal 73.9, 73.5, and 73.4 years, respectively. This suggests an average loss of life expectancy equal to 2.5, 2.9, and 3.1 years, respectively. Obviously, earlier onset ages of susceptibility result in greater Age (years) Figure 3 . Survival curves based on projected U.S. life tables and alternative excess risk assumptions. Abbreviation: RR, relative risk.
overall loss of life. Differences in assumptions about the age when susceptibility begins, however, make only small differences for the younger ages because of the relatively low baseline mortality risks.
Survival curve five in Figure 3 was calculated from the baseline curve assuming an additional relative risk of mortality from cigarette smoking from age 20 equal to 2.00. This is approximately the average relative risk of approximately average levels of smoking versus never smoking that was estimated in both the Harvard Six-Cities study (162) and the ACS study (163) . The estimated average life expectancy for smokers was 67.9, a loss of life expectancy equal to 8.6 years. Clearly, .cigarette smoking has a much larger impact on mortality than ambient air pollution. However, this estimate of loss of life expectancy is not a population average, but the average loss to smokers only.
The sixth curve was calculated from the baseline curve assuming an additional relative risk of mortality from PM exposure equal to only 1.15. This is approximately the relative risk that was estimated from the ACS study (163) for the relevant range of PM air pollution in the United States (Table 4) . Susceptibility was assumed to begin after infancy at age 1 year. The estimated life expectancy was 74.6, a loss of life expectancy equal to 1.8 years. These results are comparable to those obtained from two similar analyses (198, 199) .
Although the elevated risk associated with particulate air pollution exposure is relatively small compared with cigarette smoking, the public health significance of fine particulate air pollution, at least as measured in population average loss of life, is substantial for two basic reasons. Exposure is ubiquitous. Because fine particles are often generated indoors and ambient fine particles penetrate many indoor environments, essentially everyone is exposed. Furthermore, exposure is not a voluntary decision made as a teenager or in adulthood but occurs throughout life.
The above estimates of population average life lost from the pollution are probably a worst-case scenario for the United States. They use relatively large estimates of excess risk from chronic exposure to pollution from the recent prospective cohort studies of adults and the postneonatal infant mortality study. They assume that the risk effects are cumulative for all or a large part of persons' lives, and they assume lifelong residency in one of the most polluted U.S. cities. Loss of life estimates due to pollution exposure of 1-3 years for lifelong residents of highly polluted cities, however, is not unreasonable, especially in some of the more polluted cities in the world.
